Knowledge Hubs
The latest news on genitourinary oncological disease states.
Prostate Cancer Knowledge Hubs
Advertisement
Advertisement
Urothelial Carcinoma Knowledge Hubs
Testicular, Penile, and Rare Malignancies Knowledge Hubs
Roundtable Discussions
The panel discussed optimal treatment cycles for enfortumab vedotin/pembrolizumab.
The panel shared their thoughts on the EV-302 study.
The panel kicked off with conversations about data released at ESMO, including EV-302 and CheckMate 901.
The panel shares their hopes for the future of bladder cancer treatment.
The panel shares tips for community oncologists who may not be familiar with treating patients with EV/pembro.
The panel shares treatment sequencing decisions based on a few patient scenarios.
Advertisement
Advertisement
Editorial Advisory Board
Brian Rini, MD, FASCOEditor | Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center
Thomas Powles, MBBS, MRCP, MDEditor | Director, Barts Cancer Centre at St. Bartholomew's Hospital
Catherine H. Marshall, MD, MPHEditor | Assistant Professor of Oncology at the Johns Hopkins University School of Medicine
Jérémie Calais, MD, MScEditor | Director of the Theranostics and Clinical Research Programs at the University of California, Los Angeles
Akhil Abraham Saji, MDAssociate Editor | Fellow at the University of Southern California
David Ambinder, MDAssociate Editor | Urology Resident at New York Medical College/Westchester Medical Center
